Effects of past history of major depression on smoking characteristics, monoamine oxidase-A and -B activities and withdrawal symptoms in dependent smokers

Drug and Alcohol Dependence

Volumn 45, Issue 1-2, 1997, Pages 31-37

  Berlin, Ivan ^a   Spreux Varoquaux, Odile ^b   Saïd, Sophie ^a,d   Launay, Jean Marie ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b CENTRE HOSPITALIER DE VERSAILLES   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d HÔPITAL FERNAND WIDAL   (France)

Author keywords

Dependent smokers; Monoamine oxidases; Past history of depression; Withdrawal symptoms

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; NORADRENALIN;

ADULT; ANXIETY; ARTICLE; BODY MASS; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DEPRESSION; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; NORADRENALIN BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; SMOKING CESSATION; WITHDRAWAL SYNDROME;

ADULT; ANXIETY; BIOGENIC MONOAMINES; COTININE; DEPRESSIVE DISORDER; FEMALE; HUMANS; ISOENZYMES; MALE; MONOAMINE OXIDASE; PSYCHIATRIC STATUS RATING SCALES; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0031008468     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(97)01338-0     Document Type: Article

References (38)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, DSM-IV, Washington DC.
2. Anda, R.F., Williamson, D.F., Escobedo, L.G., Mast, E.E., Giovino, G.A. and Remington, P.L. (1990) Depression and the dynamics of smoking. JAMA 264, 1541-1545.
3. Berlin, I., Said, S., Spreux-Varoquaux, O., Olivares, R., Launay, J.M. and Puech, A.J. (1995a) Monoamine oxidase A and B activities in heavy smokers. Biol. Psychiatry 38, 759-761.
4. Berlin, I., Saïd, S., Spreux-Varoquaux, O., Launay, J.M., Olivares, R., Millet, V., Lecrubier, Y. and Puech, A.J. (1995b) A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers. Clin. Pharmacol. Ther. 58, 444-452.
5. Berlin, I., Berlan, M., Crespo-Laumonnier, B., Landault, C., Payan, C., Puech, A.J. and Turpin, G. (1990) Alterations in beta-adrenergic sensitivity and platelet alpha-2 adrenoceptors in obese women: effect of exercise and caloric restriction. Clin. Sci. 78, 81-87.
6. Boehringer, K., Beretta-Piccoli, C., Weidemann, P., Meier, A. and Ziegler, W. (1982) Pressor factors and carciovascular pressor responsiveness in lean and overweight normal and hypertensive subjects. Hypertension 4, 697-702.
7. Breslau, N., Kilbey, M.M. and Andreski, P. (1991) Nicotine dependence, major depression, and anxiety in young adults. Arch. Gen. Psychiatry 48, 1069-1074.
8. Covey, L.S., Glassman, A.H. and Stetner, F. (1990) Depression and depressive symptoms in smoking cessation. Comp. Psychiatry 31, 350-354.
9. Dalack, G.W., Glassman, A.H., Rivelli, S., Covey, L.S. and Stetner, F. (1995) Mood, major depression, and fluoxetine response in cigarette smokers. Am. J. Psychiatry 152, 398-403.
10. Coper, H., Fähndrich, E., Gebert, A., Helmchen, H., Honecker, H., Müller-Oerlinghausen, B. and Pietzcker, A. (1979) Depression and monoamine oxidase. Prog. Neuro-Psychopharmacol. 3, 441-463.
11. Edwards, D.J., Spiker, D.G., Kupfer, D.J., Foster, F.G., Neil, J.F. and Abrams, L. (1978) Platelet monoamine oxidase in affective disorders. Arch. Gen. Psychiatry 35, 1443-1446.
12. Eisenhofer, G., Goldstein, D.S., Stull, R., Keiser, H.R., Sunderland, T., Murphy, D.L. and Kopin, I.J. (1986) Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin. Chem. 32, 2030-2033.
13. Fagerström, K.O. and Schneider, N. (1989) Measuring nicotine dependence: A review of the Fagerström tolerance questionnaire J. Behav. Med. 12, 159-182.
14. Fowler, J.S., Volkow, N.D., Wang, G.-J., Pappas, N., Logan, J., MacGregor, R., Alexoff, D., Shea, C., Schlyer, D., Wolf, A.P., Warner, D., Zezulkova, I. and Cilento, R. (1996) Inhibition of monoamine oxidase B in the brains of smokers. Nature 379, 733-736.
15. Frederick, T., Frerichs, R.R. and Clark, V.A. (1988) Personal health habits and symptoms of depression at the community level. Prev. Med. 17, 173-182.
16. Glassman, A.H. (1993) Cigarette smoking: implications for psychiatric illness. Am. J. Psychiatry 150, 546-553.
17. Glassman, A.H., Covey, L.S., Dalack, G.W., Stetner, F., Rivelli, S.K., Fleiss, J. and Cooper, T.B. (1993) Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin. Pharmacol. Ther. 54, 670-679.
18. Glassman, A.H., Heizer, J.E., Covey, L.S., Cottler, L.B., Stetner, F., Tipp, J.E. and Johnson, J. (1990) Smoking, smoking cessation and major depression. JAMA 264, 1546-1549.
19. Glassman, A.H., Stetner, F., Walsh, T., Raizman, P.S., Fleiss, J.L., Cooper, T.B. and Covey, L.S. (1988) Heavy smokers, smoking cessation and clonidine. JAMA 259, 2863-2866.
20. Hamilton, M. (1959) The assessment of anxiety by rating. Br. J. Med. Psychol. 32, 50-55.
21. Honecker, H., Fähndrich, Coper, H. and Helmchen, H. (1981) Serum DBH and platelet MAO in patients with depressive disorders. Pharmakopsychiat 14, 10-14.
22. Krall, J.F., Connelly, M., Weisbart, R. and Tuck, M.L. (1981) Age-related elevation of plasma catecholamine concentration and reduced responsiveness of lymphocyte adenylate cyclase. J. Clin. Endocrinol. Metab. 52, 863-867.
23. Landowski, J., Lysiak, W. and Angielski, S. (1975) Monoamine oxidase activity in blood platelets from patients with cyclophrenic depressive syndromes. Biochem. Med. 14, 347-354.
24. Leckman, J.F., Gershon, E.S., Nichols, A.S. and Murphy, D.L. (1977) Reduced MAO activity in first degree relatives of individuals with bipolar affective disorders. Arch. Gen. Psychiatry 34, 601-606.
25. Lecrubier, Y., Sheehan, D., Weiller, E., Amorim, P., Bonora, I., Sheehan, K., Janas, J. and Dunbar, G.C. (1997) The MINI international neuropsychiatric interview (MINI): A short structured diagnostic interview. Reliability and validity according to the CIDI. Eur. Psychiatry (in press).
26. Lee, D.J. and Markides, K.S. (1991) Health behaviors, risk factors, and health indicators associated with cigarette use in Mexican Americans: results from the Hispanic HANES. Am. J. Public Health 81, 859-864.
27. Montgomery, S.A. and Asberg, M. (1979) A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134, 382-389.
28. Murphy, D.L. and Weiss, R. (1972) Reduced monoamine oxidase activity in blood platelets from bipolar depressed patients. Am. J. Psychiatry 128, 1351-1357.
29. Musselman, D.L. and Nemeroff, C.B. (1995) Adrenal function in major depression. Endocrinologist 5, 91-96.
30. Nies, A., Robinson, D.S., Harris, L.S. and Lamborn, K.R. (1974) Comparison of monoamine oxidase substrate activities in twins, schizophrenics, depressives and controls. In: Neuropsychopharmacology of Monoamines and their Regulatory Enzymes (Usdin, E., ed.), pp 59-70. Raven Press, New York.
31. Norman, T.R., Chamberlain, K.G. and French, M.A. (1987) Platelet monoamine oxidase: Low activity in cigarette smokers. Psychiatry Res. 20, 199-205.
32. Oreland, L., Fowler, C.J. and Schalling, D. (1981a) Low platelet monoamine oxidase activity in cigarette smokers. Life Sci. 29, 2511-2518.
33. Oreland, L., Wiberg, A., Asberg, M., Träskman, L., Sjöstrand, L., Thorén, P., Bertilsson, L. and Tybring, G. (1981b) Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls. Psychiatry Res. 4, 21-29.
34. Poirier, M.F., Lôo, H., Mitrani, N., Benkelfat, C., Askienazy, S. and Le Fur, G. (1987) Platelet MAO activity in clinical subtypes of depression and DST suppression. Acta Psychiatr. Scand. 75, 456-463.
35. Puzynski, S., Hauptmann, M. and Zaluska, M. (1983) Studies on biogenic amine metabolizing enzymes (oBH, COMT, MAO) and pathogenesis of affective illness. III. Platelet monoamine oxidase activity in endogeneous depression. Acta Psychiatr. Scand. 67, 101-108.
36. Samson, J.A., Gudeman, J.E., Schatzberg, A.F., Kizuka, P.P., Orsulak, P.S., Cole, J.O. and Schildkraut, J.J. (1985) Toward a biochemical classification of depressive disorders - VIII. Platelet monoamine oxidase activity in subtypes of depressions. J. Psychiat. Res. 19, 547-555.
37. Veith, R.C., Lewis, N., Linares, O.A., Barnes, R.F., Raskind, M.A., Villacres, E.C., Murburg, M., Ashleigh, A., Castillo, S., Peskind, E.R., Pascualy, M. and Halter, J.B. (1994) Sympathetic nervous system activity in major depression. Arch. Gen. Psychiatry 51, 411-422.
38. West, R.J., Hajek, P. and Belcher, M. (1989) Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking. Psycholog. Med. 19, 981-985.